This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Xenetic Biosciences 将来の成長
Future 基準チェック /16
Xenetic Biosciences's earnings are forecast to decline at 37.8% per annum while its annual revenue is expected to grow at 7% per year. EPS is expected to grow by 30.6% per annum.
主要情報
-37.8%
収益成長率
30.6%
EPS成長率
| Biotechs 収益成長 | 36.4% |
| 収益成長率 | 7.0% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 16 May 2023 |
今後の成長に関する最新情報
更新なし
Recent updates
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -17 | N/A | N/A | 1 |
| 12/31/2024 | 2 | -11 | N/A | N/A | 1 |
| 12/31/2023 | 2 | -7 | N/A | N/A | 1 |
| 3/31/2023 | 2 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 2 | -7 | -5 | -5 | N/A |
| 9/30/2022 | 2 | -7 | -6 | -5 | N/A |
| 6/30/2022 | 1 | -7 | -6 | -5 | N/A |
| 3/31/2022 | 1 | -6 | -5 | -5 | N/A |
| 12/31/2021 | 1 | -6 | -5 | -5 | N/A |
| 9/30/2021 | 1 | -5 | -4 | -4 | N/A |
| 6/30/2021 | 1 | -11 | -4 | -4 | N/A |
| 3/31/2021 | 1 | -11 | -5 | -5 | N/A |
| 12/31/2020 | 0 | -11 | -4 | -4 | N/A |
| 9/30/2020 | 0 | -11 | -5 | -5 | N/A |
| 6/30/2020 | 0 | -14 | -6 | -6 | N/A |
| 3/31/2020 | 0 | -14 | -6 | -6 | N/A |
| 12/31/2019 | 0 | -18 | -6 | -6 | N/A |
| 9/30/2019 | N/A | -19 | -6 | -6 | N/A |
| 6/30/2019 | N/A | -10 | -5 | -5 | N/A |
| 3/31/2019 | N/A | -11 | -6 | -6 | N/A |
| 12/31/2018 | N/A | -7 | -6 | -6 | N/A |
| 9/30/2018 | 8 | -1 | -1 | -1 | N/A |
| 6/30/2018 | 8 | -2 | -1 | -1 | N/A |
| 3/31/2018 | 8 | -3 | 0 | 0 | N/A |
| 12/31/2017 | 8 | -4 | 1 | 1 | N/A |
| 9/30/2017 | 3 | -12 | -8 | -8 | N/A |
| 6/30/2017 | 3 | -13 | -7 | -7 | N/A |
| 3/31/2017 | 3 | -58 | -7 | -7 | N/A |
| 12/31/2016 | 3 | -58 | N/A | -9 | N/A |
| 9/30/2016 | N/A | -57 | N/A | -5 | N/A |
| 6/30/2016 | N/A | -60 | N/A | -6 | N/A |
| 3/31/2016 | N/A | -14 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -13 | N/A | -5 | N/A |
| 9/30/2015 | N/A | -13 | N/A | -7 | N/A |
| 6/30/2015 | N/A | -11 | N/A | -8 | N/A |
| 3/31/2015 | N/A | -13 | N/A | -11 | N/A |
| 12/31/2014 | N/A | -14 | N/A | -13 | N/A |
| 9/30/2014 | N/A | -14 | N/A | -12 | N/A |
| 6/30/2014 | N/A | -13 | N/A | -12 | N/A |
| 3/31/2014 | 1 | -11 | N/A | -9 | N/A |
| 12/31/2013 | 1 | -9 | N/A | -6 | N/A |
| 9/30/2013 | 1 | -7 | N/A | -5 | N/A |
| 6/30/2013 | 1 | -6 | N/A | -5 | N/A |
| 3/31/2013 | 0 | -6 | N/A | -5 | N/A |
| 12/31/2012 | 0 | -6 | N/A | -6 | N/A |
| 9/30/2012 | 0 | -6 | N/A | -6 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: 3XB0 is forecast to remain unprofitable over the next 3 years.
収益対市場: 3XB0 is forecast to remain unprofitable over the next 3 years.
高成長収益: 3XB0 is forecast to remain unprofitable over the next 3 years.
収益対市場: 3XB0's revenue (7% per year) is forecast to grow faster than the German market (4.6% per year).
高い収益成長: 3XB0's revenue (7% per year) is forecast to grow slower than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if 3XB0's Return on Equity is forecast to be high in 3 years time